The right screening strategy for carbapenemase-producing organisms will vary depending on your particular circumstances. This session will consider existing guidance on this matter, with illustrative examples from the experience of the team at Imperial, managing both a large acute period of transmission to the current situation of ongoing detection of cases and smaller transmission events.

Dr Eimear Brannigan, Imperial College London